Arch Therapeutics, Inc. Quarterly Operating Margin in % from Q1 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Arch Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q1 2021 to Q2 2024.
  • Arch Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2024 was -3.19K %, a 76.7% increase year-over-year.
  • Arch Therapeutics, Inc. annual Operating Margin for 2023 was -6.66K %, a 81.7% increase from 2022.
  • Arch Therapeutics, Inc. annual Operating Margin for 2022 was -36.5K %, a 33.9% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -3.19K +10.5K +76.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -3.61K +13.1K +78.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -4.56K +27.2K +85.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -6.66K +29.8K +81.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 -13.7K +24.6K +64.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -16.8K +54.1K +76.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -31.8K +9.12K +22.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -36.5K +18.7K +33.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -38.3K +21.8K +36.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -70.8K -15.1K -27% Jan 1, 2022 Mar 31, 2022
Q4 2021 -40.9K Oct 1, 2021 Dec 31, 2021
Q3 2021 -55.1K Jul 1, 2021 Sep 30, 2021
Q2 2021 -60.1K Apr 1, 2021 Jun 30, 2021
Q1 2021 -55.8K Jan 1, 2021 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.